U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. Transparency
  4. FDA-TRACK: Agency-wide Program Performance
  5. FDA-TRACK: Office of Operations Dashboard
  1. FDA-TRACK: Agency-wide Program Performance

FDA-TRACK: Office of Operations Dashboard

FDA's Office of Operations (OO) provides leadership for operational activities, interaction and execution of program initiatives across the Office of the Commissioner (OC) and FDA centers, field offices and regions.  OO assures that the conduct of agency administrative and financial management activities effectively support program operations.

The Chief Operating Officer (COO) has agency-wide authority for strengthening the management of business programs and operations of the agency. The COO oversees day-to-day management issues, effective implementation of Congressional and Commissioner priorities and initiatives, and the delivery of quality services by the agency and its centers.

OO provides an array of agency-wide services including information technology, procurement, and facilities.  OO provides leadership and direction regarding delegation of authority, freedom of information, privacy act, and regulatory dockets management and ethics and conflict of interest matters.  OO provides executive administrative management services to the OC nationwide staff.

Each FDA-TRACK program area collects, analyzes, and reports its performance measures and results. Explore the progress OO is making to protect public health below:

Measures are under development and will be available once finalized.

I. Dockets Management Measures

A. Ensure high-quality Federal Register (FR) processing, with no errors, in order to eliminate the need for an FR correction notice to be published and resulting in cost penalties

  1. Number of Federal Register Docket Research requests received in the month by the Division of Information Governance (DIG)

    Completed Measures and Key Projects

    Note:  The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time.

    Sign up to receive FDA-TRACK updates

    Get regular FDA email updates delivered on this topic to your inbox.

    Back to Top